Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | CYP2U1 |
| Upstream (Parents) |
|---|
| (<<) ANTXR2 → CYP2U1 |
| (<<) ELK3 → CYP2U1 |
| (<<) GNAI1 → CYP2U1 |
| (<<) GULP1 → CYP2U1 |
| (<<) ITGB5 → CYP2U1 |
| (<<) LOC399959 → CYP2U1 |
| (<<) LRRC8C → CYP2U1 |
| (<<) NRN1 → CYP2U1 |
| (<<) PAK4 → CYP2U1 |
| (<<) PLA2G4A → CYP2U1 |
| (<<) RECK → CYP2U1 |
| (<<) ROR1 → CYP2U1 |
| (<<) TP53 → CYP2U1 |
| (<<) UST → CYP2U1 |
| Downstream (Children) |
|---|
| CYP2U1 → CFL2 (>>) |
| CYP2U1 → FADS2 (>>) |
| CYP2U1 → FUT4 (>>) |
| CYP2U1 → GPNMB (>>) |
| CYP2U1 → INVS (>>) |
| CYP2U1 → NR3C1 (>>) |
| CYP2U1 → PARD6G (>>) |
| CYP2U1 → PELO (>>) |
| CYP2U1 → PKIA (>>) |
| CYP2U1 → PRKCSH (>>) |
| CYP2U1 → PTPLA (>>) |
| CYP2U1 → RORA (>>) |
| CYP2U1 → SGMS2 (>>) |
| CYP2U1 → SH3KBP1 (>>) |
| CYP2U1 → SOCS5 (>>) |
